Part 812 - Investigational Device Exemptions (IDE)

Part 812 of Title 21 CFR governs Investigational Device Exemptions, allowing manufacturers to conduct clinical studies on medical devices that have not yet received marketing approval. It sets requirements for IDE applications, sponsor responsibilities, monitoring, and reporting to ensure participant safety and data integrity during the investigational phase.